Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Savara Inc. SVRA
$2.00
+$0.06 (3.09%)
На 18:00, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
221286100.00000000
-
week52high
2.85
-
week52low
1.08
-
Revenue
0
-
P/E TTM
-8
-
Beta
0.85882300
-
EPS
-0.25000000
-
Last Dividend
0.00000000
-
Next Earnings Date
09 мая 2023 г. в 10:59
Описание компании
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Piper Sandler | Overweight | 16 мар 2021 г. | |
| Oppenheimer | Outperform | 15 мар 2021 г. | |
| HC Wainwright & Co. | Buy | Buy | 15 дек 2020 г. |
| JMP Securities | Market Perform | Outperform | 13 июн 2019 г. |
| Evercore ISI Group | Outperform | 08 июн 2018 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| RAMSAY DAVID A | A | 2101142 | 29000 | 30 дек 2022 г. |
| RAMSAY DAVID A | A | 2072142 | 7000 | 29 дек 2022 г. |
| RAMSAY DAVID A | A | 2065142 | 3293 | 28 дек 2022 г. |
| RAMSAY DAVID A | A | 2061849 | 15707 | 23 дек 2022 г. |
| Pratt Raymond Dennis | A | 153500 | 3500 | 22 дек 2022 г. |
| RAMSAY DAVID A | A | 2046142 | 41414 | 22 дек 2022 г. |
| RAMSAY DAVID A | A | 2004728 | 3586 | 20 дек 2022 г. |
| RAMSAY DAVID A | A | 2001142 | 13830 | 20 дек 2022 г. |
| RAMSAY DAVID A | A | 1987312 | 40719 | 19 дек 2022 г. |
| RAMSAY DAVID A | A | 1946593 | 341 | 16 дек 2022 г. |
Новостная лента
Savara to Present at the Oppenheimer 33rd Annual Healthcare Conference
Business Wire
06 мар 2023 г. в 16:05
AUSTIN, Texas--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will present at the Oppenheimer 33rd Annual Healthcare Conference on March 13, 2023 at 1:20pm ET. A live webcast of the presentation will be available on Savara's website at www.savarapharma.com/investors/events-presentations/ and will be archived for 90 days.
Why Shares of Savara Soared This Week
The Motley Fool
27 янв 2023 г. в 15:47
The clinical-stage biopharmaceutical company focuses on therapies to treat rare respiratory diseases.
Savara to Present at H.C. Wainwright 24th Annual Global Investment Conference
Business Wire
01 сент 2022 г. в 08:05
AUSTIN, Texas--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that Matt Pauls, Chair and CEO, Savara will present at the H.C. Wainwright 24th Annual Global Investment Conference being held September 12-14, 2022. A webcast of the presentation will be available at 7:00 AM ET/4:00 AM PT on September 12, 2022 on Savara's website at www.savarapharma.com/investors/events-presentations/ and archived for 90 d
3 Top Breakout Stocks to Add to Your Portfolio Now
Zacks Investment Research
08 июл 2022 г. в 08:33
Savara (SVRA), LGL Group (LGL) and Harte Hanks (HHS) have been selected as the breakout stocks for today.
Savara to Present at Jefferies Healthcare Conference
Business Wire
01 июн 2022 г. в 16:05
AUSTIN, Texas--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will present at the Jefferies Healthcare Conference on June 8, 2022 at 1:00 pm ET in New York City. A live webcast of the presentation will be available on Savara's website at www.savarapharma.com/investors/events-presentations/ and will be archived for 90 days. About Savara Savara is a clinical stage biopharmaceuti